FindTrial
Sign In

Compare The Effect Of Kutajashtak Churna And Samangadi Kwath On Heavy Periods

A Comparative Clinical Study Of Kutajashtak Churna And Samangadi Kwath On Asrigdara W.S.R. To Menometrorrhagia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046596
Enrollment
40
Registered
2022-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle Health Condition 2: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

Madan Mohan Malviya Govt Ayurved college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 patients willing for the trial 2 patients between the age group of 18-45 years 3 patients with either one or all symptoms of Asrigdara like Ritu Atipravritti (excessive bleeding during menstruation) Deergha Pravritti (prolonged bleeding)

Exclusion criteria

Exclusion criteria: 1 patients before 18 years and after 45 years of age 2 patients with uterine and pelvic pathology like big fibroid carcinoma cervix cervical polyp endometrial carcinoma chronic medical illness etc 3 bleeding due to coagulation disorders 4 patients had bleeding due to abortions

Design outcomes

Primary

MeasureTime frame
improvement in the sign & symptoms from the treatment in the patientsTimepoint: 3 months—

Secondary

MeasureTime frame
efficacy of treatmentTimepoint: 3 months—

Countries

India

Contacts

Public ContactProf Mahesh Dixit

Madan Mohan Malviya Govt Ayurved college

prof.maheshdixit@gmail.com9414245459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026